Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody.
Kerob
Delphine
D
Dupuy
Alain
A
Reygagne
Pascal
P
Levy
Annabelle
A
Morel
Patrice
P
Bernard
Bruno A
BA
Lebbé
Céleste
C
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary; D000068818:Cetuximab; D066246:ErbB Receptors; D005145:Face; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced* / Q000473:pathology; D007866:Leg; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab